Characterization of mutant Ha-ras gene expression in transformed murine keratinocyte lines grown under in vitro and in vivo conditions

Molecular Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 202-206

  Volpe, John P G ^a,b   Conti, Claudio J ^a   Slaga, Thomas J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE   (United States)

Author keywords

papilloma; ras; squamous cell carcinoma; tumor cell lines

Indexed keywords

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE MUTATION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL DIVISION; CELL LINE, TRANSFORMED; GENE EXPRESSION; GENES, RAS; KERATINOCYTES; MICE; MICE, NUDE; MUTATION; PAPILLOMA; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0030475973     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199612)17:4<202::AID-MC3>3.0.CO;2-F     Document Type: Article

References (32)

1. H oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines. Carcinogenesis 8:1821-1825, 1987,
2. Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80, 1986.
3. Khosravi-Far R, Der CJ. The ras signal transduction pathway. Cancer Metastasis Rev 13:67-89, 1994.
4. Lowe PN, Skinner RH. Regulation of ras signal transduction in normal and transformed cells. Cell Signal 6:109-123, 1994.
5. Bowden GT, Schneider B, Domann R, Kulesz-Martin M. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res 54:1882s-1885s, 1994.
6. Strom SC, Faust JB, Cappelluti E, Harris RB, Lalwani ND. Characterization of liver epithelial cells transfected with myc and/or ras oncogenes. Dig Dis Sci 36:642-652, 1991.
7. Coleman WB, Throneburg DB, Grisham JW, Smith GJ. Overexpression of c-K-ras, c-NI-ras, and transforming growth factor beta co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines. Carcinogenesis 15:1005-1012, 1994.
8. Spandidos DA, Frame M, Wilkie NM. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes. Anticancer Res 10:1543-1554, 1990.
9. Martin GS. Rous sarcoma virus - a function required for the maintenance of the transformed state. Nature 227:1021-1023, 1970.
10. Kimura E, Armelin HA. Role of proto-oncogene c-Ki-ras amplification and overexpression in the malignancy of Y-1 adrenocortical tumor cells. Braz J Med Biol Res 21:189-201, 1988.
11. Brown K, Buchmann A, Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for progression. Proc Natl Acad Sci USA 87:538-542, 1990.
12. Kashani-Sabet M, Funato T, Florenes VA, Fodstad O, Scanlon KJ. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res 54:900-902, 1994.
13. Ruch RJ, Madhukar BV, Trosko JE, Klaunig JE. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Mol Carcinog 7:50-59, 1993.
14. Slaga TJ, O'Connell J, Rotstein J, et al. Critical genetic determinants and molecular events in multistage skin carcinogenesis. In: Becker FF, Slaga TJ (eds), Critical Molecular Determinants of Carcinogenesis. University of Texas Press, Austin, TX, 1987, pp. 31-44.
15. Conti CJ, Aldaz CM, O'Connell J, Klein-Szanto AJP, Slaga TJ. Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis 7:1845-1848, 1986.
16. Conti CJ, Fries KW, Viaje A, Miller DR, Slaga TJ. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res 48:435-439, 1988.
17. Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J. Tumor progression in SENCAR mouse skin as a function of initiator dose and promoter dose, duration, and type. Cancer Res 48:7048-7054, 1988.
18. Aldaz CM, Conti CJ, Chen A, Bianchi A, Walker SB, DiGiovanni J. Promoter independence as a feature of most skin papillomas in SENCAR mice. Cancer Res 51:1045-1050, 1991.
19. Aldaz CM, Conti CJ, Klein-Szanto AJP, Slaga TJ. A direct cytogenetic technique for mouse skin carcinomas and papillomas. Cancer Genet Cytogenet 20:223-229, 1986.
20. Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ, Yamasaki H. Gapjunctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. Cancer Res 49:699-705, 1989.
21. Miller DR, Viaje A, Aldaz CM, Conti CJ, Slaga TJ. Terminal differentiation-resistant epidermal cells in mice undergoing two-stage carcinogenesis. Cancer Res 47:1935-1940, 1987.
22. Wiser MF, Schweiger H. Increased sensitivity in antigen detection during immunoblot analysis resulting from antigen enrichment via immunoprecipitation. Anal Biochem 155:71-77, 1986.
23. Furth ME, Aldrich TH, Cordon-Cardo C. Expression of ras protooncogene proteins in normal human tissues. Oncogene 1:47-58, 1987.
24. Heegaard NHH and Bjerrum OJ. Immunoblotting-general principles and procedures. In: Heegaard NHH, Bjerrum OJ (eds), CRC Handbook of Immunoblotting of Proteins. Volume 1, Technical Descriptions. CRC Press, Boca Raton, FL, 1988, pp. 1-24.
25. Bianchi AB, Navone NM, Conti CJ. Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. Am J Pathol 138:279-284, 1991.
26. Worst PKM, Valentine EA, Fusenig NE. Formation of epidermis after reimplantation of pure primary epidermal cell cultures from perinatal mouse skin. J Natl Cancer Inst 53:1061-1064, 1974.
27. Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ, Yamasaki H. Gapjunctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. Cancer Res 49:699-705, 1989.
28. Zar JH. Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, NJ, 1984.
29. Volpe JPG. Genetic instability of cancer: Why a metastatic tumor is unstable and a benign tumor is stable. Cancer Genet Cytogenet 34:125-134, 1988.
30. Aldaz CM, Conti CJ, O'Connell J, Yuspa SH, Klein-Szanto AJP, Slaga TJ. Cytogenetic evidence for gene amplification in mouse skin carcinogenesis. Cancer Res 46:3565-3568, 1986.
31. Stackpole CW, Fornabaio DM, Alterman AL. Phenotypic interconversion of B16 melanoma clonal cell populations: Relationship between metastasis and tumor growth rate, Int J Cancer 35:667-674, 1985.
32. Vaage J. Loss of spontaneous metastasizing potential in mouse mammary tumors. Clin Exp Metastasis 7:373-378, 1989.